Literature DB >> 15358702

Surfactant proteins in pulmonary alveolar proteinosis in adults.

F Brasch1, J Birzele, M Ochs, S H Guttentag, O D Schoch, A Boehler, M F Beers, K M Müller, S Hawgood, G Johnen.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disorder characterised histologically by an intra-alveolar accumulation of fine granular eosinophilic and periodic acid-Schiff positive material. In a retrospective study, the composition of the intra-alveolarly accumulated material of adult patients with PAP was analysed by means of immunohistochemistry and Western blotting. In patients with PAP, the current authors found an intra-alveolar accumulation of surfactant protein (SP)-A, precursors of SP-B, SP-B, variable amounts of mono-, di-, and oligomeric SP-C forms, as well as SP-D. Only in one patient was a precursor of SP-C detected. By means of immuno-electron microscopy, the current authors identified not only transport vesicles labelled for precursors of SP-B and SP-C, but also transport vesicles containing either precursors of SP-B or SP-C in type-II pneumocytes in normal human lungs. It is concluded that pulmonary alveolar proteinosis in adults is characterised by an intra-alveolar accumulation of surfactant protein A, precursors of surfactant protein B, and surfactant proteins B, C and D. The current data provide evidence that not only an impairment of surfactant clearance by alveolar macrophages, but also an abnormal secretion of transport vesicles containing precursors of surfactant protein B (but not surfactant protein C) and an insufficient palmitoylation of surfactant protein C, which may lead to the formation of di- and oligomeric surfactant protein C forms, play a role in the pathogenesis of pulmonary alveolar proteinosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358702     DOI: 10.1183/09031936.04.00076403

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

Review 1.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

2.  Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease.

Authors:  Mari Tanaka-Kubota; Koji Shinozaki; Satoshi Miyamoto; Masakatsu Yanagimachi; Tsubasa Okano; Noriko Mitsuiki; Masahiro Ueki; Masafumi Yamada; Kohsuke Imai; Masatoshi Takagi; Kazunaga Agematsu; Hirokazu Kanegane; Tomohiro Morio
Journal:  Int J Hematol       Date:  2017-11-28       Impact factor: 2.490

3.  Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.

Authors:  Andrew Ferretti; Jarrod R Fortwendel; Sarah A Gebb; Robert A Barrington
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

4.  Atypical pulmonary alveolar proteinosis presenting as a mixed nodular ground-glass opacity with focal mucinosis mimicking lung cancer.

Authors:  Tsutomu Shinohara; Hiroyuki Hino; Shino Imanishi; Keishi Naruse; Yuji Ohtsuki; Fumitaka Ogushi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

5.  Spontaneous pulmonary alveolar proteinosis in captive "moustached tamarins" (Saguinus mystax).

Authors:  C R Michaud; D R Ragland; K I Shea; P M Zerfas; R J Kastenmayer; M C St Claire; W R Elkins; A S Gozalo
Journal:  Vet Pathol       Date:  2011-07-06       Impact factor: 2.221

6.  Surfactant proteins in pediatric interstitial lung disease.

Authors:  Matthias Griese; Elke Lorenz; Meike Hengst; Andrea Schams; Traudl Wesselak; Daniela Rauch; Thomas Wittmann; Valerie Kirchberger; Amparo Escribano; Thomas Schaible; Winfried Baden; Johannes Schulze; Heiko Krude; Charalampos Aslanidis; Nicolaus Schwerk; Matthias Kappler; Dominik Hartl; Peter Lohse; Ralf Zarbock
Journal:  Pediatr Res       Date:  2015-09-16       Impact factor: 3.756

7.  The untranslated exon B of human surfactant protein A2 mRNAs is an enhancer for transcription and translation.

Authors:  Patricia Silveyra; Manmeet Raval; Brett Simmons; Susan Diangelo; Guirong Wang; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-12       Impact factor: 5.464

Review 8.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

Review 9.  Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

10.  Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease.

Authors:  Matthias Griese; Silja Schumacher; Mohammed Tredano; Manuela Steinecker; Annika Braun; Susan Guttentag; Michael F Beers; Michel Bahuau
Journal:  Respir Res       Date:  2005-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.